Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04206215 · ClinicalTrials.gov registry record · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
A NA study of Chronic Pain and Carpal Tunnel Syndrome, sponsored by Spaulding Rehabilitation Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 95
- Enrollment target
- 1
- Study location
NCT04206215: Recruiting NA study of Chronic Pain and Carpal Tunnel Syndrome, sponsored by Spaulding Rehabilitation Hospital.
NCT04206215 is a NA study of Chronic Pain and Carpal Tunnel Syndrome that is actively recruiting participants, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 95 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04206215, a NA study of Chronic Pain and Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by Spaulding Rehabilitation Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
Primary Outcome
Changes in the Visual Analogue Scale (VAS) for pain will be measured in order to determine whether anodal transcranial direct current stimulation in conjunction with transcranial ultrasound is effective in reducing pain in subjects with Carpal Tunnel Syndrome. The VAS scale goes from 0 up to 10, where 0 means no pain at all and 10 means the worst imaginable pain.
Conditions Studied
Interventions
- DEVICE transcranial Direct Current Stimulation (tDCS)
- DEVICE Transcranial Ultrasound (TUS)
Study Locations (1)
Massachusetts
- Spaulding Rehabilitation Network Research Institute - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2021-04-16 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT04206215 shows while recruiting
NCT04206215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT04206215 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04206215 about?
NCT04206215 is a clinical study titled "Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome". The purpose of this study is to assess the effects of tDCS in combination with TUS for the treatment of pain in subjects with Carpal Tunnel Syndrome. The investigators hypothesize that there will be a decrease in pain levels with active stimulation, when compared to sham stimulation.
What is the current status of trial NCT04206215?
This trial is currently recruiting. It is a NA study. The enrollment target is 95 participants. The study started on 2021-04-16. Estimated completion is 2027-02-28.
What conditions does trial NCT04206215 study?
This clinical trial studies the following conditions: Chronic Pain, Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT04206215?
The interventions under investigation include: transcranial Direct Current Stimulation (tDCS) (DEVICE), Transcranial Ultrasound (TUS) (DEVICE).
Who is sponsoring clinical trial NCT04206215?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04206215 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04206215's enrollment target sits among peer trials
95 142nd of 301 higher than 159 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04542161 · 95 participants · Phase 2
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI